The information conveyed about new products has critical downstream implications that can affect the appropriate receiving, handling and storage at the distributor’s facility and farther along the healthcare...
This interactive course is made up of 11 modules illustrating the key pharmaceutical supply chain stakeholders and their functions as products move from the manufacturer to the customer.
Developed by HDA’s Returns Task force, these voluntary guidelines (last updated in 2007) provide insights into industry recall and withdrawal practices, downstream trading partner actions, and internal/external...
NON - MEMBER PRICE: $0.00 | MEMBER PRICE: $0.00
From the point of receipt by a distributor to the point of delivery to a customer, the proper temperature of cold chain or frozen products must be maintained during product storage and transportation....
PRICE : $0.00 - $495.00
Add to Cart
These guidelines educate trading partners across the healthcare supply chain in the processes used for the negotiation and administration of contracts, as well as the submission, validation and reconciliation...
PRICE : $0.00 - $75.00
Add to Cart
This white paper provides a brief overview of the pharmaceutical supply chain, product supply issues and current processes that can result in product shortages.
PRICE : $0.00 - $0.00
Add to Cart
Developed by HDMA’s Returns Task Force, this summary reports the volume and average dollar value of returned prescription and over-the-counter products processed by reverse logistics providers.
PRICE : $0.00 - $495.00
Add to Cart
Developed by the HDMA Returns Task Force, this article identifies ways to reduce unsalable returns and reduce supply chain waste.
Download PDF
Trading partners may use this sample returned goods debit memo template to clearly convey the pertinent information about returned pharmaceuticals and facilitate the credit reconciliation process.
PRICE : $0.00 - $0.00
Add to Cart
This report focuses on the opportunities to improve communications between trading partners as a branded pharmaceutical product nears the end of its patent protection to better manage inventory and reduce...
PRICE : $0.00 - $0.00
Add to Cart
Developed by HDMA’s Returns Task Force, this report addresses key issues and recommends process improvements for returned or unsalable healthcare products.
PRICE : $0.00 - $495.00
Add to Cart
These recommendations suggest practices that a pharmaceutical entity could employ to identify and help minimize the risks associated with storing pharmaceutical products.
PRICE : $0.00 - $495.00
Add to Cart
Violent attacks are increasing in the last mile for pharmaceutical supply chain distribution. These suggested guidelines offer companies seeking to strengthen their in-transit security program a directed...
PRICE : $0.00 - $495.00
Add to Cart